Archiv článků

Ranibizumab in the ARMD Wet Form Treatment – Two Years Results Obtained from the AMADEuS Registry Journal > /cs/journal/2012/5/1
Aim: The aim of this study was the retrospective follow up of Age-Related Macular Degeneration (ARMD) wet form patients treated with ranibizumab during 24 months period. The data were recorded into the AMADEuS (Age-related MAcular DEgeneration in patientS in the Czech Republic) Registry and after their evaluation compared with treatment results obtained from other departments of ophthalmology coll...